ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 222 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $418,000 | -24.0% | 10,086 | +33.1% | 0.10% | -35.8% |
| Q1 2022 | $550,000 | +67.7% | 7,580 | +94.4% | 0.15% | +32.1% |
| Q4 2021 | $328,000 | +11.9% | 3,900 | +20.0% | 0.11% | +17.9% |
| Q3 2021 | $293,000 | +20.6% | 3,250 | +27.5% | 0.10% | -5.0% |
| Q2 2021 | $243,000 | -40.7% | 2,550 | -29.2% | 0.10% | -60.3% |
| Q1 2021 | $410,000 | -27.7% | 3,600 | -72.8% | 0.25% | +17.8% |
| Q3 2019 | $567,000 | +34.0% | 13,244 | +50.7% | 0.21% | -48.7% |
| Q4 2018 | $423,000 | – | 8,790 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |